HCID 53629212, compound → HCID 15952967, compound
Reaction equation
COC1C=C(OC)C=CC=1C[NH:6][C:7]1[CH:8]=[CH:9][C:10]2[N:11]([C:13]([CH2:20][N:21]3[CH2:25][CH:24]([CH2:26][CH2:27][CH3:28])[CH2:23][C:22]3=[O:29])=[C:14]([C:16]([F:19])([F:18])[F:17])[N:15]=2)[N:12]=1>FC(F)(F)C(O)=O>[NH2:6][C:7]1[CH:8]=[CH:9][C:10]2[N:11]([C:13]([CH2:20][N:21]3[CH2:25][CH:24]([CH2:26][CH2:27][CH3:28])[CH2:23][C:22]3=[O:29])=[C:14]([C:16]([F:18])([F:17])[F:19])[N:15]=2)[N:12]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
1-{[6-[(2,4-dimethoxybenzyl)amino]-2-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]methyl}-4-propylpyrrolidin-2-one x268 (396 mg, 0.83 mmol) is stirred at room temperature in trifluoroacetic acid until its complete consumption (17 hours). After TFA removal under reduced pressure, the residue is taken in saturated K2CO3 aqueous solution and extracted with ethyl acetate (3×15 ml). The cumulated organic layers are dried over MgSO4, filtered and condensed under reduced pressure to yield the crude material which is purified by reverse phase preparative chromatography (gradient acetonitrile/water/TFA) to afford 1-{[6-amino-2-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]methyl}-4-propylpyrrolidin-2-one 53.
Workup
- customAfter TFA removal under reduced pressure
- extractionextracted with ethyl acetate (3×15 ml)
- dry with materialThe cumulated organic layers are dried over MgSO4
- filtrationfiltered
- customcondensed under reduced pressure
- customto yield the crude material which
- customis purified by reverse phase preparative chromatography (gradient acetonitrile/water/TFA)
Sources & evidence
- ORD record
- ord-c0938023e9c148da9e8ed4cb4e09d942
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08178533B2
Reaction notes
Loading…